Decibel Therapeutics IPO

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine.

Register for Details

For more details on financing and valuation for Decibel Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Decibel Therapeutics's ticker symbol?


What is Decibel Therapeutics's stock price?

5 as of 9/19/23

Learn more about Decibel Therapeutics

Forge green plus iconForge green minus icon

What is Decibel Therapeutics funding to date?

Decibel Therapeutics has raised $132.06MM to date.
Forge green plus iconForge green minus icon

When was Decibel Therapeutics founded?

Decibel Therapeutics was founded in 2015.
Updated on: Jun 12, 2022